- Home
- / Strides Pharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Stock Price
₹274.8
2023-03-24
Market Capitalization
₹24.8 B
2023-03-24
Revenue
₹30.2 B
FY, 2022
CreditSafe score
?
Score changed on Mar 27, 2023
Premium Content
Learn moreFinancial statements
| INR | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 |
|---|---|---|---|---|---|
| Revenue | 33.0B | 29.4B | 28.9B | 32.5B | 30.2B |
| Cost of goods sold | 14.2B | 15.0B | 11.8B | 14.1B | 15.8B |
| Gross profit | 27.8B | 15.2B | 18.2B | 19.1B | 14.9B |
| Gross profit margin, % | 84.3% | 51.7% | 63.0% | 58.9% | 49.2% |
| Operating expense total | 16.9B | 10.4B | 12.5B | 12.6B | 15.0B |
| Depreciation and amortization | 2.1B | 1.8B | 1.9B | 2.1B | 2.3B |
| EBITDA | 10.8B | 4.4B | 4.6B | 5.6B | (1.2B) |
| EBITDA margin, % | 32.7% | 14.8% | 15.9% | 17.2% | -4.1% |
| EBIT | 8.3B | 2.6B | 1.9B | 4.0B | (5.9B) |
| EBIT margin, % | 25.1% | 8.7% | 6.5% | 12.4% | -19.6% |
| Interest income | 90.1M | 222.8M | 368.9M | 353.0M | 1.1B |
| Interest expense | 2.0B | 2.1B | 1.6B | 1.5B | 1.8B |
| Pre tax profit | 7.1B | 3.4B | 485.1M | 2.9B | (6.5B) |
| Income tax expense | 214.1M | 144.9M | 179.1M | 316.5M | (1.8B) |
| Net Income | 6.8B | 3.3B | 306.0M | 2.6B | (4.7B) |
Footer menu
Products
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension